Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02095353 : Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor Patients
PhaseN/A
AgesMin: 19 Years Max: N/A
Eligibility
Inclusion Criteria:

- Subjects with brain tumors will be enrolled. These subjects may be newly diagnosed,
undergoing treatment or undergoing follow-up. If a subject has undergone surgery or
treatment they should have what appears to be residual tumor.

Exclusion Criteria:

- Renal failure (GFR <45). Subjects will be screened utilizing UNMC gadolinium contrast
guidelines.

- Allergic reactions to MRI contrast agents.

- Subjects who do not fit the criteria for the population we are evaluating.

- Subjects should not participate in this study if they have any of the following
conditions:

- Anxiety attacks

- Panic disorder

- Claustrophobia

- Pregnant, or trying to become pregnant

- Breast feeding

- Subjects should not participate in this study if they have certain kinds of metal in
their body, for example: a heart pacemaker, defibrillator, neurostimulator, a metal
plate, certain otologic implants, certain types of heart valves, metal slivers in
eye, brain aneurysm clips or metal slivers and bullet fragments in or near certain
structures in their body. Our standard MRI safety screening will be performed on all
subjects.

- If a subject has metal in their body that requires an additional x-ray beyond what is
needed for the clinical MRI examination to safely perform the research MRI
examination that subject would be excluded.Subjects not being able to return for a
follow-up examination
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02095353      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740